Tacrolimus(Midatech)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameTacrolimus(Midatech)
Drug Alias NameMTD-219
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionImmunosuppressantsBone morphogenetic protein receptor type-2 modulatorsT cell activation inhibitors +[5] 
TargetsBone morphogenetic protein receptor type-2CytokinesCalcineurin
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiodexa Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesBiodexa Pharmaceuticals PLC
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A